• news

Awarded the Healthcare Innovation Prize in the "Mirai Cross 2023" Acceleration Program.

Celaid Therapeutics participated in the final judging session of "Mirai X (mirai cross) 2023", an incubation and acceleration program by SMBC Group held on January 16, 2023, and received the "Healthcare Innovation Award"!

■ Judging Results (Corporate Awards by Company Partners)

[Company Partner] Mitsui Chemicals, Inc.
[Name of Award] Healthcare Innovation Award
[Name of the winning team] Celaid Therapeutics Inc.
[Business Plan] Development of cell therapy products for leukemia and other diseases using human hematopoietic stem cell expnasion technology

Copyright© セレイドセラピューティクス - 細胞治療(造血幹細胞) , 2024 All Rights Reserved Powered by STINGER.